Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145597113> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3145597113 endingPage "53" @default.
- W3145597113 startingPage "49" @default.
- W3145597113 abstract "Abstract Objective To study the mutual relationship between anti-HBx and IL-10, IL-12 or soluble Fas (sFas) in sera of patients with chronic HBV infection and to explore the importance of anti-HBx detection as well as its role in the development of chronic HBV infection. Methods Total of 90 cases with chronic HBV infection were randomly selected, including 10 of asymptomatic carriers (ASC), 28 of chronic hepatitis B (CHB), 26 of liver cirrhosis (LC) and 26 patients of hepatocellular carcinoma (HCC). Their clinical data and blood samples were collected, and serum was prepared and stored at -73℃. Anti-HBx was detected with an indirect ELISA established in our earlier research, and levels of IL-10, IL-12 and Fas were determined with commercial double-antibody sandwich ELISA kits. The mutual relationship between anti-HBx and IL-10, IL-12 or sFas in serum were analyzed with the software SPSS 20.0. Results All levels of IL-10, IL-12 and sFas in peripheral blood showed a rising trend with development of chronic HBV infection. The levels of IL-10 in ASC, CHB, LC and HCC groups were 13.93 ± 14.40 ng/L, 39.38 ± 20.77 ng/L, 69.06 ± 46.37 ng/L and 62.82 ± 23.42 ng/L, respectively, levels of IL-12 in the 4 groups were 15.64 ± 23.04 ng/L, 68.50 ± 23.14 ng/L, 76.83 ± 12.82 ng/L and 83.74 ± 24.88 ng/L, respectively, and levels of sFas were 58.17 ± 77.42 ng/L, 179.88 ± 104.36 ng/L, 249.22 ± 107.80 ng/L and 252.98 ± 87.65 ng/L, respectively. Twenty-seven out of 90 patients showed a positive result for anti-HBx detection, including 1 in ASC, 4 in CHB, 12 in LC and 10 in HCC group. The levels of IL-10, IL-12 and sFas were higher in anti-HBx positive group than in negative group. Statistical analysis demonstrated significant differences of IL-10 and IL-12 between the two groups (P < 0.05), but the differences of sFas had no statistical significance (P = 0.094). Conclusions Anti-HBx antibody is not protective, and is closely related to IL-10, IL-12 and sFas. It may be an important serum indicator for aggravation from chronic hepatitis B to liver cirrhosis or hepatocellular carcinoma in patients with chronic HBV infection." @default.
- W3145597113 created "2021-04-13" @default.
- W3145597113 creator A5011562555 @default.
- W3145597113 creator A5033635647 @default.
- W3145597113 creator A5064333183 @default.
- W3145597113 creator A5066275875 @default.
- W3145597113 creator A5071037763 @default.
- W3145597113 creator A5083478186 @default.
- W3145597113 date "2014-06-01" @default.
- W3145597113 modified "2023-10-18" @default.
- W3145597113 title "Studies on Mutual Relationship between Anti-HBx and sFas, IL-10 or IL-12 in Sera of Cases with Chronic Hepatitis B Infection" @default.
- W3145597113 doi "https://doi.org/10.1515/ii-2017-0075" @default.
- W3145597113 hasPublicationYear "2014" @default.
- W3145597113 type Work @default.
- W3145597113 sameAs 3145597113 @default.
- W3145597113 citedByCount "0" @default.
- W3145597113 crossrefType "journal-article" @default.
- W3145597113 hasAuthorship W3145597113A5011562555 @default.
- W3145597113 hasAuthorship W3145597113A5033635647 @default.
- W3145597113 hasAuthorship W3145597113A5064333183 @default.
- W3145597113 hasAuthorship W3145597113A5066275875 @default.
- W3145597113 hasAuthorship W3145597113A5071037763 @default.
- W3145597113 hasAuthorship W3145597113A5083478186 @default.
- W3145597113 hasBestOaLocation W31455971131 @default.
- W3145597113 hasConcept C126322002 @default.
- W3145597113 hasConcept C203014093 @default.
- W3145597113 hasConcept C2522874641 @default.
- W3145597113 hasConcept C2777214474 @default.
- W3145597113 hasConcept C2777910003 @default.
- W3145597113 hasConcept C2778019345 @default.
- W3145597113 hasConcept C2780593183 @default.
- W3145597113 hasConcept C3020491458 @default.
- W3145597113 hasConcept C67567795 @default.
- W3145597113 hasConcept C71924100 @default.
- W3145597113 hasConcept C90924648 @default.
- W3145597113 hasConceptScore W3145597113C126322002 @default.
- W3145597113 hasConceptScore W3145597113C203014093 @default.
- W3145597113 hasConceptScore W3145597113C2522874641 @default.
- W3145597113 hasConceptScore W3145597113C2777214474 @default.
- W3145597113 hasConceptScore W3145597113C2777910003 @default.
- W3145597113 hasConceptScore W3145597113C2778019345 @default.
- W3145597113 hasConceptScore W3145597113C2780593183 @default.
- W3145597113 hasConceptScore W3145597113C3020491458 @default.
- W3145597113 hasConceptScore W3145597113C67567795 @default.
- W3145597113 hasConceptScore W3145597113C71924100 @default.
- W3145597113 hasConceptScore W3145597113C90924648 @default.
- W3145597113 hasIssue "2" @default.
- W3145597113 hasLocation W31455971131 @default.
- W3145597113 hasOpenAccess W3145597113 @default.
- W3145597113 hasPrimaryLocation W31455971131 @default.
- W3145597113 hasRelatedWork W2361363104 @default.
- W3145597113 hasRelatedWork W2371034248 @default.
- W3145597113 hasRelatedWork W2397616890 @default.
- W3145597113 hasRelatedWork W2412677110 @default.
- W3145597113 hasRelatedWork W3030034291 @default.
- W3145597113 hasRelatedWork W3030449887 @default.
- W3145597113 hasRelatedWork W4253189515 @default.
- W3145597113 hasRelatedWork W4317759110 @default.
- W3145597113 hasRelatedWork W1714311310 @default.
- W3145597113 hasRelatedWork W2101010353 @default.
- W3145597113 hasVolume "3" @default.
- W3145597113 isParatext "false" @default.
- W3145597113 isRetracted "false" @default.
- W3145597113 magId "3145597113" @default.
- W3145597113 workType "article" @default.